Lates News

According to a brief report released by PuYin International Securities on September 1, Goomer Medical (688236.SH) was rated as a buy with a target price of 27.20 yuan. The rating reasons mainly include: 1) Income growth resumed in the first half of the year, with net profit achieving high growth driven by income growth and significant decrease in expense ratio; 2) Overseas business maintained high growth; 3) Multiple new products were approved for listing, and the potential sector continued to strengthen. (Everyday Economics News)